VANGUARD GROUP INC 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Sale |
2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
VANGUARD GROUP INC | 1,475,350 3.650% |
-673,703 (-31.35%) |
Filing |
| 2022-02-10 08:28 am Purchase |
2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
VANGUARD GROUP INC | 2,149,053 5.330% |
2,149,053 (New Position) |
Filing |